Clinical Trials in San Diego

Showing 5801-5820 of 11,146 trials

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

NCT04271514

This study is a first-in-human, 3-part, multi-center, Phase 1, randomized, double-blind, placebo-controlled study with RPT193 in up to 64 healthy male and female subjects and 30 male and female patients with atopic dermatitis. RPT193 is an orally-available, potent, and selective antagonist of CCR4.

Atopic Dermatitis

RAPT Therapeutics, Inc.103 participantsStarted Aug 2019

Anniston, Alabama, United States • Scottsdale, Arizona, United States • San Diego, California, United States +11 more locations

COMPLETED< 1 mile

Rad-67 Repeatability and Reproducibility

NCT04196907

The primary objective of this clinical investigation is to evaluate the repeatability and reproducibility of using Rad-67 Pulse CO-Oximeter

Healthy

Masimo Corporation20 participantsStarted Nov 2019

San Diego, California, United States

TERMINATEDPhase 3< 1 mile

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

NCT02952586

This is a phase 3 randomized, placebo controlled study to evaluate the safety and anti-tumor activity of Avelumab in combination with standard of care chemoradiation (SoC CRT) versus SoC CRT alone in front-line treatment of patients with locally advanced head and neck cancer.

Squamous Cell Carcinoma of the Head and Neck

Pfizer697 participantsStarted Nov 2016

Fayetteville, Arkansas, United States • Rogers, Arkansas, United States • Springdale, Arkansas, United States +313 more locations

A First-in-Human Study of RPT193 in Healthy Volunteers and Patients With Atopic Dermatitis

Rad-67 Repeatability and Reproducibility

Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100)

Find Trials by Condition in San Diego

Study to Investigate Efficacy and Safety of PF-04965842 in Subjects Aged 12 Years and Over With Moderate to Severe Atopic Dermatitis With the Option of Rescue Treatment in Flaring Subjects

Dose Range Study of CD5789 in Acne Vulgaris

Phase 2B Efficacy/Safety of Ornithine Phenylacetate in Hospitalized Cirrhotic Patients With Hepatic Encephalopathy (STOP-HE)

Personalized Blood Pressure Care Using IoMTs and Artificial Intelligence

Medical Assistant Health Coaching for Diabetes in Diverse Primary Care Settings

A Phase 1/2, Open-label, Dose Finding Study to Evaluate CC-122 in Combination With Ibrutinib and Obinutuzumab in Subjects With Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

Evaluation of Subchondroplasty™ for Defects Associated With Bone Marrow Lesions

A Study of the Effects of GC4419 on Radiation Induced Oral Mucositis in Patients With Head/Neck Cancer

Omnitram Safety and Efficacy in the Treatment of Diabetic Neuropathy

Study of Denosumab as Adjuvant Treatment for Women With High Risk Early Breast Cancer Receiving Neoadjuvant or Adjuvant Therapy (D-CARE)

An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension

Study of Tesevatinib Monotherapy in Patients With Recurrent Glioblastoma

Neoadjuvant GW572016 to Treat Breast Cancer

Assessing Symptomatic Clinical Episodes in Depression

Stress Management for Cancer Patients: How Well Does it Work? (C2H-D)

A Study Evaluating Pertuzumab (Perjeta) Combined With Trastuzumab (Herceptin) and Standard Anthracycline-based Chemotherapy in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Locally Advanced, Inflammatory, or Early-stage Breast Cancer

Therapeutic Evaluation of Steroids in IgA Nephropathy Global Study (TESTING Low Dose Study)